GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sigyn Therapeutics Inc (OTCPK:SIGY) » Definitions » E10

SIGY (Sigyn Therapeutics) E10 : $-205.28 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Sigyn Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sigyn Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2025 was $-0.420. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-205.28 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-07-19), Sigyn Therapeutics's current stock price is $2.80. Sigyn Therapeutics's E10 for the quarter that ended in Mar. 2025 was $-205.28. Sigyn Therapeutics's Shiller PE Ratio of today is .


Sigyn Therapeutics E10 Historical Data

The historical data trend for Sigyn Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigyn Therapeutics E10 Chart

Sigyn Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -210.77

Sigyn Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -217.55 -216.08 -210.77 -205.28

Competitive Comparison of Sigyn Therapeutics's E10

For the Biotechnology subindustry, Sigyn Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sigyn Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sigyn Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sigyn Therapeutics's Shiller PE Ratio falls into.


;
;

Sigyn Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sigyn Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.42/134.9266*134.9266
=-0.420

Current CPI (Mar. 2025) = 134.9266.

Sigyn Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201506 -119.994 100.684 -160.804
201509 -179.991 100.392 -241.909
201512 111.991 99.792 151.420
201603 -179.991 100.470 -241.719
201606 -59.997 101.688 -79.608
201609 -59.997 101.861 -79.473
201612 0.000 101.863 0.000
201703 -59.997 102.862 -78.699
201706 -119.994 103.349 -156.657
201709 -179.991 104.136 -233.211
201712 -119.994 104.011 -155.660
201803 -59.997 105.290 -76.885
201806 -29.798 106.317 -37.817
201809 -59.997 106.507 -76.006
201812 -119.994 105.998 -152.742
201903 3.983 107.251 5.011
201906 -8.624 108.070 -10.767
201909 -10.400 108.329 -12.953
201912 -225.188 108.420 -280.242
202003 -10.670 108.902 -13.220
202006 -20.800 108.767 -25.803
202009 -23.600 109.815 -28.997
202012 -0.514 109.897 -0.631
202103 -0.400 111.754 -0.483
202106 -0.800 114.631 -0.942
202109 -0.800 115.734 -0.933
202112 -1.200 117.630 -1.376
202203 -0.800 121.301 -0.890
202206 -0.800 125.017 -0.863
202209 -0.800 125.227 -0.862
202212 -0.730 125.222 -0.787
202303 -1.390 127.348 -1.473
202306 -0.670 128.729 -0.702
202309 -0.820 129.860 -0.852
202312 -0.940 129.419 -0.980
202403 -0.620 131.776 -0.635
202406 -0.700 132.554 -0.713
202409 -0.940 133.029 -0.953
202412 -0.250 133.157 -0.253
202503 -0.420 134.927 -0.420

Add all the adjusted EPS together and divide 10 will get our e10.


Sigyn Therapeutics  (OTCPK:SIGY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sigyn Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Sigyn Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Sigyn Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
2468 Historic Decatur Road, Suite 140, San Diego, CA, USA, 92106
Sigyn Therapeutics Inc is a development-stage therapeutic technology company. Its business focus is the clinical advancement of Sigyn Therapy, a multi-function blood purification technology designed to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths world-wide. To support widespread implementation, the company designed Sigyn Therapy to be a single-use disposable device that is deployable on the world-wide infrastructure of hemodialysis and continuous renal replacement therapy machines already located in hospitals and clinics.
Executives
Joseph Segelman director, 10 percent owner, officer: President & CEO 9190 W OLYMPIC BLVD, # 263, BEVERLY HILLS CA 90212
Australian Sapphire Corp 10 percent owner 9190 W OLYMPIC BLVD, BEVERLY HILLS CA 90212
Chaya Segelman director, officer: Secretary 9190 W OLYMPIC BLVD, # 263, BEVERLY HILLS CA 90212